Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Fischer

Showing results (1261-1270 of 1,361) with videos related to

Pageof 137
Sort By:
Angewandte Chemie (International Ed. in English)|November 27, 2024
A Kinetic Scout Approach Accelerates Targeted Protein Degrader DevelopmentAngela T Fan, Gillian E Gadbois, Hai-Tsang Huang, et al.
European Journal of Medicinal Chemistry|April 23, 2021
A biphenyl inhibitor of eIF4E targeting an internal binding site enables the design of cell-permeable PROTAC-degradersPatrick D Fischer, Evangelos Papadopoulos, Jon M Dempersmier, et al.
RSC Chemical Biology|September 21, 2022
Cereblon covalent modulation through structure-based design of histidine targeting chemical probesJustin T Cruite, Geoffrey P Dann, Jianwei Che, et al.
Brain : a Journal of Neurology|June 4, 1999
Development of a multiple sclerosis functional composite as a clinical trial outcome measureG R Cutter, M L Baier, R A Rudick, et al.
Chembiochem : a European Journal of Chemical Biology|April 23, 2023
Development and Characterization of Selective FAK Inhibitors and PROTACs with In Vivo ActivityEriko Koide, Mikaela L Mohardt, Zainab M Doctor, et al.
Nature|April 1, 2016
Cullin-RING ubiquitin E3 ligase regulation by the COP9 signalosomeSimone Cavadini, Eric S Fischer, Richard D Bunker, et al.
European Urology|July 6, 2019
Fibroblast Growth Factor Receptor 3 Alterations and Response to PD-1/PD-L1 Blockade in Patients with Metastatic Urothelial CancerLi Wang, Yixuan Gong, Abdel Saci, et al.
Journal of Medicinal Chemistry|April 10, 2023
Catalytic Degraders Effectively Address Kinase Site Mutations in EML4-ALK Oncogenic FusionsYang Gao, Baishan Jiang, Hellen Kim, et al.
Canadian Journal of Diabetes|July 12, 2025
Blood characteristics of patients with type 2 diabetes and response of their peripheral blood mononuclear cells to inhibitors of the NLRP3-inflammasome and caspase-1Joyce de Paula Souza, Justus S Fischer, Karine Jeanneau, et al.
Tissue Engineering. Part A|May 16, 2024
Elevated Shear Stress Modulates Heterogenous Cellular Subpopulations to Induce Vascular RemodelingKatharina S Fischer, Dominic Henn, Eric T Zhao, et al.
Pageof 137

Showing results (1261-1270 of 1,361) with videos related to

Sort By:
Pageof 137
Angewandte Chemie (International Ed. in English)|November 27, 2024
A Kinetic Scout Approach Accelerates Targeted Protein Degrader DevelopmentAngela T Fan, Gillian E Gadbois, Hai-Tsang Huang, et al.
European Journal of Medicinal Chemistry|April 23, 2021
A biphenyl inhibitor of eIF4E targeting an internal binding site enables the design of cell-permeable PROTAC-degradersPatrick D Fischer, Evangelos Papadopoulos, Jon M Dempersmier, et al.
RSC Chemical Biology|September 21, 2022
Cereblon covalent modulation through structure-based design of histidine targeting chemical probesJustin T Cruite, Geoffrey P Dann, Jianwei Che, et al.
Brain : a Journal of Neurology|June 4, 1999
Development of a multiple sclerosis functional composite as a clinical trial outcome measureG R Cutter, M L Baier, R A Rudick, et al.
Chembiochem : a European Journal of Chemical Biology|April 23, 2023
Development and Characterization of Selective FAK Inhibitors and PROTACs with In Vivo ActivityEriko Koide, Mikaela L Mohardt, Zainab M Doctor, et al.
Nature|April 1, 2016
Cullin-RING ubiquitin E3 ligase regulation by the COP9 signalosomeSimone Cavadini, Eric S Fischer, Richard D Bunker, et al.
European Urology|July 6, 2019
Fibroblast Growth Factor Receptor 3 Alterations and Response to PD-1/PD-L1 Blockade in Patients with Metastatic Urothelial CancerLi Wang, Yixuan Gong, Abdel Saci, et al.
Journal of Medicinal Chemistry|April 10, 2023
Catalytic Degraders Effectively Address Kinase Site Mutations in EML4-ALK Oncogenic FusionsYang Gao, Baishan Jiang, Hellen Kim, et al.
Canadian Journal of Diabetes|July 12, 2025
Blood characteristics of patients with type 2 diabetes and response of their peripheral blood mononuclear cells to inhibitors of the NLRP3-inflammasome and caspase-1Joyce de Paula Souza, Justus S Fischer, Karine Jeanneau, et al.
Tissue Engineering. Part A|May 16, 2024
Elevated Shear Stress Modulates Heterogenous Cellular Subpopulations to Induce Vascular RemodelingKatharina S Fischer, Dominic Henn, Eric T Zhao, et al.
Pageof 137